Literature DB >> 21818129

Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

M B Kashkouli1, F Pakdel, V Kiavash, I Heidari, A Heirati, S Jam.   

Abstract

PURPOSE: To compare demographics, severity, and activity of thyroid eye disease (TED) in patients with hyperthyroidism (Hr-TED) vs primary hypothyroidism (Ho-TED). PATIENTS AND METHODS: In a cross-sectional study, demographics, complete eye examination, severity score (NOSPECS, total hundred eye score), clinical activity score, and Rundle grading were recorded for patients with TED and different thyroid disorders referred from an endocrinology clinic from 2003 to 2006.
RESULTS: TED was clinically found in 303 patients (303/851, 35.6%). The majority of them (280/303, 92.4%) had Graves' hyperthyroidism and 23 (23/303, 7.5%) had primary hypothyroidism. Mean age, gender, mean severity score, mean activity score, Rundle grade, unilateral presentation of TED, smoking habit, mean duration of eye disease, and mean interval time of thyroid to TED were not significantly different between the two groups (0.06<P<0.9). Mean duration of thyroid disease was significantly (P=0.02) longer in the Hr-TED group (49.6 months) than in the Ho-TED group (22.7 months). Most of the patients in both groups (63.2% of Hr-TED and 73.9% of Ho-TED) developed the eye disease within 18 months before or after the thyroid disease.
CONCLUSION: The same demographics, clinical characteristics, and severity and activity scores for Hr-TED and Ho-TED imply that both groups present the same category of eye disease.

Entities:  

Mesh:

Year:  2011        PMID: 21818129      PMCID: PMC3213650          DOI: 10.1038/eye.2011.186

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  34 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.

Authors:  Mark F Prummel; Annemieke Bakker; Wilmar M Wiersinga; Lelio Baldeschi; Maarten P Mourits; Pat Kendall-Taylor; Petros Perros; Chris Neoh; A Jane Dickinson; John H Lazarus; Carol M Lane; Armin E Heufelder; George J Kahaly; Suzanne Pitz; Jacques Orgiazzi; Alain Hullo; Aldo Pinchera; Claudio Marcocci; Maria S Sartini; Roberto Rocchi; Marco Nardi; Gerry E Krassas; A Halkias
Journal:  Eur J Endocrinol       Date:  2003-05       Impact factor: 6.664

3.  The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy.

Authors:  K P Cockerham; C Pal; B Jani; A Wolter; J S Kennerdell
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

4.  [Malignant exophtalmos in hyperthyroidism with a hypothyroid crisis].

Authors:  J Campos-Pavón; E Mencía-Gutiérrez; E Gutiérrez-Díaz
Journal:  Arch Soc Esp Oftalmol       Date:  2006-12

5.  Ophthalmopathy associated with primary hypothyroidism.

Authors:  B E Brownlie; O A Newton; S P Singh
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

6.  Hypothyroid Graves' disease.

Authors:  J H Christy; R S Morse
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

7.  Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.

Authors:  A K Eckstein; C Lösch; D Glowacka; M Schott; K Mann; J Esser; N G Morgenthaler
Journal:  Br J Ophthalmol       Date:  2009-02-15       Impact factor: 4.638

8.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

9.  Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy.

Authors:  R Kalmann; M P Mourits
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

10.  Infiltrative ophthalmopathy and primary hypothyroidism: a rare clinical manifestation of a common disease.

Authors:  R Rajput; A Dhingra; K Kumar; J Sen
Journal:  Postgrad Med J       Date:  2009-01       Impact factor: 2.401

View more
  11 in total

1.  Corneal biomechanical changes and intraocular pressure in patients with thyroid orbitopathy.

Authors:  Zofia Pniakowska; Anna Klysik; Roman Gos; Piotr Jurowski
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

Review 2.  A Systematic Review on the Role of Antioxidants in Thyroid Eye Disease.

Authors:  Shadi Akbarian; Samira Chaibakhsh; Mohsen Bahmani Kashkouli; Nasser Karimi; Parya Abdolalizadeh; Hossein Ghahvehchian
Journal:  J Curr Ophthalmol       Date:  2022-04-16

3.  Graves' Ophthalmopathy in the Setting of Primary Hypothyroidism.

Authors:  Sarah Alajmi; Sara Alshehri; Aishah Ekhzaimy
Journal:  Cureus       Date:  2022-05-12

4.  Comparative Clinicopathological Evaluation of the Ocular Surface in Newly Diagnosed Patients of Hyperthyroidism and Hypothyroidism Compared to Healthy Subjects.

Authors:  Nidhi Paharia; Indu Arora; Nikhil Agrawal; Abha Mathur; Shruti Agrawal
Journal:  Cureus       Date:  2022-04-06

5.  Second degree AV block and severely impaired contractility in cardiac myxedema: a case report.

Authors:  Apostolos Chatzitomaris; Michael Scheeler; Michael Gotzmann; Roland Köditz; Janice Schildroth; Kathy Miriam Knyhala; Volkmar Nicolas; Christoph Heyer; Andreas Mügge; Harald H Klein; Johannes W Dietrich
Journal:  Thyroid Res       Date:  2015-05-19

6.  Beyond a typical thyroid eye disease.

Authors:  Mohsen Bahmani Kashkouli
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

7.  The epidemiological characteristics of patients with thyroid eye disease in a referral center in northern Iran.

Authors:  Abdolreza Medghalchi; Mitra Akbari; Yousef Alizadeh; Reza Soltani Moghadam
Journal:  J Curr Ophthalmol       Date:  2018-07-19

8.  Clinical profile of thyroid eye disease and factors predictive of disease severity.

Authors:  Alankrita Muralidhar; Sima Das; Sweety Tiple
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

9.  Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.

Authors:  Aditi Pandit; Abhay Gundgurthi; Sandeep Kharb; Karninder S Brar; M K Garg
Journal:  Indian J Endocrinol Metab       Date:  2013-03

10.  Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Maria Camila Sierra-Cote; Estefanía Zapata-Bravo; Laura Valenzuela-Vallejo; Maria Alejandra Marin-Noriega; Pilar Uribe-Reina; Juan Pablo Terreros-Dorado; Marcela Gómez-Suarez; Karla Arteaga-Rivera; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.